Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalia Timofeeva

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Blood Cancer Journal|April 30, 2021
Ibrutinib combinations in CLL therapy: scientific rationale and clinical resultsNatalia Timofeeva, Varsha Gandhi
Blood Neoplasia|February 14, 2025
Ibrutinib and venetoclax in combination for chronic lymphocytic leukemia: synergy in practiceNatalia Timofeeva, Nitin Jain, Varsha Gandhi
Frontiers in Oncology|August 21, 2023
Targeting MCL-1 protein to treat cancer: opportunities and challengesShady I Tantawy, Natalia Timofeeva, Aloke Sarkar, et al.
Updates in Surgery|August 1, 2022
Tension-free thyroidectomy (TFT): initial reportIlya Sleptsov, Roman Chernikov, Alexander Pushkaruk, et al.
Frontiers in Oncology|May 25, 2023
Preclinical investigations of the efficacy of the glutaminase inhibitor CB-839 alone and in combinations in chronic lymphocytic leukemiaNatalia Timofeeva, Mary L Ayres, Natalia Baran, et al.
Gland Surgery|October 16, 2023
Tension-free thyroidectomy (medial thyroidectomy)-a prospective study: surgical technique and results of 259 operationsIlya Sleptsov, Roman Chernikov, Alexander Pushkaruk, et al.
Research Square|April 16, 2025
Pharmacological profiling in CLL patients during pirtobrutinib therapy and disease progressionVarsha Gandhi, Shady Tantawy, Burcu Aslan, et al.
International Journal of Laboratory Hematology|January 2, 2021
GATA1 mutation analysis and molecular landscape characterization in acute myeloid leukemia with trisomy 21 in pediatric patientsAgnesa Panferova, Marina Gaskova, Eugenyi Nikitin, et al.
International Journal of Laboratory Hematology|January 10, 2019
Acute myeloid leukemia with t(10;11)(p11-12;q23.3): Results of Russian Pediatric AML registration studyElena Zerkalenkova, Svetlana Lebedeva, Anna Kazakova, et al.
Blood Cancer Journal|May 7, 2026
Docirbrutinib is a pan-mutant BTK inhibitor and inhibits B-cell receptor signaling in chronic lymphocytic leukemia cells in preclinical and early clinical investigationsNatalia Timofeeva, Breana Herrera, Hitomi Fujiwara, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Blood Cancer Journal|April 30, 2021
Ibrutinib combinations in CLL therapy: scientific rationale and clinical resultsNatalia Timofeeva, Varsha Gandhi
Blood Neoplasia|February 14, 2025
Ibrutinib and venetoclax in combination for chronic lymphocytic leukemia: synergy in practiceNatalia Timofeeva, Nitin Jain, Varsha Gandhi
Frontiers in Oncology|August 21, 2023
Targeting MCL-1 protein to treat cancer: opportunities and challengesShady I Tantawy, Natalia Timofeeva, Aloke Sarkar, et al.
Updates in Surgery|August 1, 2022
Tension-free thyroidectomy (TFT): initial reportIlya Sleptsov, Roman Chernikov, Alexander Pushkaruk, et al.
Frontiers in Oncology|May 25, 2023
Preclinical investigations of the efficacy of the glutaminase inhibitor CB-839 alone and in combinations in chronic lymphocytic leukemiaNatalia Timofeeva, Mary L Ayres, Natalia Baran, et al.
Gland Surgery|October 16, 2023
Tension-free thyroidectomy (medial thyroidectomy)-a prospective study: surgical technique and results of 259 operationsIlya Sleptsov, Roman Chernikov, Alexander Pushkaruk, et al.
Research Square|April 16, 2025
Pharmacological profiling in CLL patients during pirtobrutinib therapy and disease progressionVarsha Gandhi, Shady Tantawy, Burcu Aslan, et al.
International Journal of Laboratory Hematology|January 2, 2021
GATA1 mutation analysis and molecular landscape characterization in acute myeloid leukemia with trisomy 21 in pediatric patientsAgnesa Panferova, Marina Gaskova, Eugenyi Nikitin, et al.
International Journal of Laboratory Hematology|January 10, 2019
Acute myeloid leukemia with t(10;11)(p11-12;q23.3): Results of Russian Pediatric AML registration studyElena Zerkalenkova, Svetlana Lebedeva, Anna Kazakova, et al.
Blood Cancer Journal|May 7, 2026
Docirbrutinib is a pan-mutant BTK inhibitor and inhibits B-cell receptor signaling in chronic lymphocytic leukemia cells in preclinical and early clinical investigationsNatalia Timofeeva, Breana Herrera, Hitomi Fujiwara, et al.
Pageof 1